None
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years old; 2. Need to undergo laparoscopic surgery and have corresponding surgical treatment indications, including but not limited to the following operations: (1) Excision of adrenal tumor; (2) Decapitating renal cyst; (3) Ureteral bladder replantation; (4) Radical prostatectomy (localized prostate cancer with clinical stage T1 or T2); (5) Nephrectomy (partial or radical); 3. Patients whose physiological condition is acceptable for laparoscopic surgery; 4. Willing to cooperate with and complete the study follow-up and related tests; 5. The subjects or their agents voluntarily participate in the experiment and sign the informed consent in person.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. The clinical stage of malignant tumor is IV; 3. Patients in need of emergency surgery; 4. Active bleeding, abnormal coagulation function (prothrombin time (PT) or International normalized ratio (INR) is 1.5 times higher than the upper limit of normal) or platelet count < 80×10^9/L; 5. Patients with serious cardiovascular or circulatory diseases who cannot tolerate surgery; 6. Participants in other clinical trials within the last 1 month; 7. Unable to understand the trial requirements, or unable to complete the study follow-up plan; 8. The researchers believe there are other conditions that are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remote surgery success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Network transmission evaluation;Robot-assisted surgery time;Intraoperative blood loss, EBL;Postoperative hospital stay;Subjective evaluation of intraoperative experience;Normal serum PSA rate after surgery (for subjects with radical prostatectomy only);Surgical margin positive rate (only for patients with malignant tumor resection); | — |
Countries
China
Contacts
Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine